Skip to main content
. Author manuscript; available in PMC: 2010 Nov 2.
Published in final edited form as: J Med Virol. 2009 Jul;81(7):1140–1150. doi: 10.1002/jmv.21493

Table I.

Relationships between JCV and BKV viraria and PML.

(PML cases/HIV-positive controls)
JCV/BKV outcome No. pairs (Nea/Neft) (Pos/Pos) (Pos/Neg) (Nep/Pos) MOR* (95%CI)

JCV Viruria
Viruria at any visit** 26 11 5 4 6 0.7 (0.1 – 2.8)
Transient Viruria 26 20 1 0 5 -
Persistent Viruria 26 17 1 6 2 3 (0.5 – 30.4)
BKV Viruria
Viruria at any visit** 26 18 0 3 5 0.6 (0.1 – 3.1)
*

Matched odds ratio and 95% confidence interval

**

JCV and BKV viruria at any visit defined as presence of JCV or BKV viruria at either visits 1,2 or 3

Persistent viruria defined as two or more consecutive visits with JCV Viruria; transient viruria defined as Viruria at one or more non-consecutive visits.